FDA issues final guidance on CMC postapproval changes for annual reports
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)ComplianceNorth AmericaQuality Assurance and ControlRegulatory Intelligence/Policy